New pill regimens published in The Lancet cure hardest-to-treat hepatitis C patients

Researchers from The University of Texas Health Science Center at San Antonio, the Texas Liver Institute and other institutions have identified a combination of pills that cures 9 of 10 hepatitis C patients.